<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 248 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page247.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=248">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 248 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 248</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=248"><img src="../thumb/248.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Urinary System - 16.1                                                          2020-04 / 211
       Contraindications: Sev.hepat.insuffic., safety in pregn.& lac-  HEXAZIDE 25, (Sandoz) Hexal  Contraindications: Hypersens.to sulphonamid., incr. azotaem.&
       tat.not est.                  Hydrochlorothiazide          oligur., anur./hypokalaem. /hyponatraem./ hypovolaem.with/without
       Side effects: Allerg.reacts., electrol.imbal., GI disturbs., headache,   Indications: Oed.assoc.with CCF/hepat.cirrhos.& nephrot.syndr.,   hypotens., hepat.coma, electrol.deplet., lactat., Tabs 500: Ren.fail.due
       orthostat.hypotens.           hypertens.as sngl./combinat.ther.  to Hg-sublimate caus. nephrotox.& in assoc.with hepat.coma, carbon
       Special precautions: Elderly, imp.ren./hepat. funct., diabet., gout   (S3) TABS, 32/18.1/0419  tetrachlor. poison. caus.hepatotox., Retard 60 & 500 mg tabs: childr.
       hist, hyperuricaem., sympathectomy, sulphonamide type med cross   890470-007: 25 mg, 100, R53,76  Side effects: Dermatit., prurit., paraesthes., blurr. vis., postur.hypo-
       sens., concom.Li not recomm., pts.at high risk of develop.hypoka-  Dosage: Indiv.dos. Init.& maint.at low.effect.dos.  tens., N&V, diarrh., allerg. reacts., bld. dyscras., hyperuricaem., liv.
              +
       laem.may req.K supplem., poss hyperkalaem.with supplementat.  Oed: 25-50 mg/day. Max.recomm.dly.dos.100 mg.  damage, lower. ser.Ca-lev., tetany, Ca deposits in ren. tiss. in prems.,
       Drug interactions: Poss.interacts.with amiodarone, coumarin or   Hypertens: Init.dos: 12,5 mg.12,5-25 mg dly.as sngl.dos. Max.  excess.diures., GI disturbs., anaphylact. shock, gout precipitat.in pre-
       indanlone-deriv. anticoags., digit.glycosides, other antihypertens.,   recomm.dly.dos.100 mg.  disp.pts. due to incr.uric acid conc., pancreatit., rehydr.& reduct. of
       non-depolaris.neuromusc.block.agents, & sympathomimet.  Contraindications: Sev.ren.& hepat.dysfunct., sulphon. deriv.meds.  bld.vol.(circulat. collapse, embol., vasc. thrombos.), excess. K-loss in
       DYNA INDAPAMIDE SR, Pharma Dynamics  hypersens., Addison’s dis., safety in pregn.& lactat.not est.  pts.receiv.card. glycosid., precipit.digital.toxic., electrol. disturbs., re-
                                                                  vers.deafn.& tinnit.with parent.use, incr. risk of persistence of patent
                                     Side effects: GI disturbs., CNS effs., parasthes., bld. dyscras., orthos-
       Indapamide.                                                ductus arterios. in prems., aggrav.of pre-exist.metabol.alkalos., CNS
       Indications: Mild to mod.hypertens.  tat.hypotens., hypersens. reacts. incl.anaphylact.reacts., metabol.&   effs., obstruct.micturit.sympts.manifest./ aggrav.
                                     electrol. disturbs., ren.dysfunct./fail., interstit.nephrit., musc. spasm,
       (S3) SR TABS, 42/7.1/0790.    weakn., restlessn., trans.blurr.vis., impot., yellow vis., cholestat.jaund.,   Special precautions: Elderly, pregn.& then only for short periods,
       716962-001: 1,5 mg, 30, R44,34  pancreatit., precipitat. of gout, exacerbat./activat.of SLE  imp.hepat./ren.funct., diab. mellit./ adren.dis., K-rich diet advisab.,
       Dosage: One SR tab.dly.pref.in the morn. May be combin.with   Special precautions: Monit.electrol.bal., imp. ren. & hepat.  K-deplet. steroid ther., correct shock bef.commenc. high dos.ther., in-
       other antihypertens.          funct., elderly, poss.diabet.agents dos. adjustm., diabet.poss.un-  fus.250 mg strength only using vol./rate controll.infus.pumps, concom.
       Contraindications: Hypersens.to other sulphonamide type meds.,   mask./aggrav.  cisplat. due to hear.damage risk, concom.chlor.hydr.not recomm., do
       sev.hepat.impairm., sev.ren.fail., safety in pregn.& lactat.not est.,   not infus./combine in same syr.with other meds., monit.for excess.
       safety & effic.in childr.not est., other concom. diuret.caus.hypoka-  Drug interactions: Toxic.of digital.glycos.poss enhanc., alcohol/  BP decr., poss.incr. K  loss with laxat.abuse., monit.ser.creatin., urea
                                                                           +
                                     barbit.& narcot.may potent. orthostat.hypotens., effs.of other anti-
       laem.not recomm.                                           & electrol. reg.dur.long-term treatm.
       Side effects: Thrombocytopen., granulocytopen., leucopaen.,   hypertens. agents potent., sev.electrol.deplet.esp. hypokalaem. with   Drug interactions: K  defic.incr.myocard.sens.to digital., cephalo-
                                                                            +
                                     corticoster.& ACTH, respons.to press. amines decr., incr.respons.to
       aplast.anaem., hypochloraem. alkalos., hyponatraem., hypokalaem.,   sporin & aminoglycosid.assoc. nephrotoxic. potent., ototox.of amino-
       hyperuricaem., skin rash, itch., pulm.oed., pneumonit., cholestat.  non-depolaris. skelet. musc.relax., poss.Li toxic., diuret./natriuret. &   glycosid.& other ototox.drugs incr., may dimin./potent other meds.
       jaund., pancreatit., headache, postur.hypotens., dizzin., anorex.,   antihypetens.eff.reduc.by NSAID’s.  effs., act.of other hypotens.meds.poss. potent., NSAID’s may antagon.
       N&V, constip., diarrh. electrol./ hypotens.effs., hypersens./allerg.  INSPRA, Pfizer  act., sucralfate decr. intestin.absorpt.
       reacts., alt.lab. test values.  Eplerenone
       Special precautions: Elderly, consid.benef.vs. risk in sev.ren.im-  Indications:.Reduc.CV death risk in stable pts. with L.ventric.dys-  LITHA FUROSEMIDE, Litha
       pairm./anur./gout hist./diab. mellit./ hyperuricaem./hepat.impairm./   funct.& clinic.evid.HF aft.ac.MI  Furosemide.
       sympathect., monit.uric acid lev.esp.with gout hist., monit.ser.K in pts.  (S4) TABS, A39/6.4/0106, 0107.  Indications: Oed.of card., hepat./ren.origin, ac.pulm.oed., cerebr.
                                +
       prone to hypokalaem., K  supplem./K spar.diurets.may be reqd., dis-  706121-002: 25 mg, 28, R679,62  oed., forced diures.
                 +
                      +
       cont.if azotaem./oligur.occurs.  706121-001: 25 mg, 30, R728,16  (S3) INJ. 29/18.1/0663. 20 mg/2 ml.
       Drug interactions: Incr.hypokalaem.assoc. arrhythm. risk with ami-  706135-001: 50 mg, 30, R728,16  825298-008: 10x2 ml amps, R24,81
       odarone, coumarin/ indandione-deriv.anticoag.eff.decr., enhanc. digi-  Dosage: Usual.admin.with std.ther.  Dosage: IV or IM. IV rate not to exceed 4 mg/min.
       talis toxic.with digital.glycosid., poss. interacts. with other antihyper-  Recomm.dos: 50 mg once dly. Init.25 mg once dly. titrat.to targ.dos.  Adults: 20-50 mg slow IVI or IM, rep.if necess.aft. 2 hrs.
       tens., enhanc.Li-toxic.risk, enhanc.blockade with neuromusc. block.   of 50 mg once dly.pref.within 4 wks.as tol.  Pulm.oed: 40 mg slow IVI follow.by 2nd dose 1 hr. later depend.on
       non-depolaris.agents, reduc.effs.with sympathomimets.  Contraindications: Hyperkalaem./condits.assoc. with hyper-  respon. May be incr.to 80 mg.
                                                                  Childr: 0,5-1,5 mg/kg bm.
                                             +
       FUROSEMIDE FRESENIUS AMP, Fresenius Kabi  kalaem., concom.K -spar.diuret., strong CYP3A4 inhibit., not recomm.  Contraindications: Sulphonam.hypersens., anur./ ren. fail.due to
       Furosemide.                   in paed.as data insuffic., pregn., lactat.  nephrotox./hepatotox.drugs, ren. fail. assoc.with hepat.coma, pre-
       Indications: 20 mg/2 ml: Card.oed.in conjunct. with adeq.gly-  Side effects: Hyperkalaem., hypotens., dizzin., GI disturbs., abnorm.  comatose states assoc. with hepat.cirrhos.,
       cos.ther., ascites due to liv.cirrh./ mech. obstruct.or card.fail., ren./  ren.funct., postur.hypotens., asthen., back pain, malaise, L card.fail.,   Side effects: Fluid & electrol.imbal., allergy, naus., diarrh., vis.dis-
       pulm./cerebr.oed., forc.diures., burns to reduc.loc.oed & prev.oligur.   leg cramps, headache, atrial fibrillat., dehydrat., hypercholesterol-  turbs., dizzin., headache, pancreatit., photosens., skin rash., hypo-
       progress.to compl.anur. 250 mg/25 ml: Oliguria in ac.& chron.ren.  aem., hypertriglyceridaem., hyponatraem., MI, insomn., pharyngit.,   tens., interstit. nephrit., bone marrow depress., bld. dyscras., hepat.
       fail., chron.ren.insuffic.    prurit., incr.sweat., eosinophil.  dysfunct., cholestat.jaund., paraesthes., deafn.& tinnit.(high dos.),
                                                  +
       (S3) INJ. K/18.1/207, Z/18.1/139.   Special precautions: Monit.K  when init.ther./ chang.dos.& pe-  glycosur., hyperglycaem., hyperuricaem., incr.Ca urin.excret, pancre-
       727687-018: 20 mg/2 ml, 10x2 ml, R46,09  riod.dur.ther.where hyperkalaem. risk poss., dos.reduct.shown to   atit., ren.stone format.
       799955-019: 250 mg/25 ml, 10x25 ml, R580,87  decr.ser.K+lev., imp.ren.funct., diabet.microalbuminur., monit. elec-  Warnings and special precautions: Monit. fluid & electrol.imbal.
       Dosage: Admin.IVI slow.over 1-2 min.  trol.in mild to mod.hepat.impairm., not eval.in sev.hepat.impairm.,   esp.in pres.of vomit./ dur. parenter.fluid ther., prostat. hypertrophy/
       Adults: Recomm.dos: 20-40 mg IV rep.if necess. aft.not less then 2   monit.ser.lev.of concom.Li  imp. micturit., imp.hepat./ren.funct., jaund.infts., pregn., lactat., cross.
       hrs. Paed.dos: Usuall.1 mg/kg bm.  Drug interactions: Signific.interacts.report.with CYP3A4 inhibit.  placent.barrier, excret. in breast milk.
       Pulm.oed: Init.40 mg IV rep.if necess.aft.approx. 60-90 mins.  eg.ketoconazole/erythromycin/ saquinavir/verapamil & fluconazole,   Interactions: Potent.cephalospor.& aminoglycoside assoc.nephro-
       Oliguria in ac.& chron.ren.fail: 250 mg dil to 250 ml in suit.dil.  other K+-spar. agents with NSAIDS have shown sev.hyperkalaem. in   toxic., phenytoin & indomethacin may reduc.clinic.eff.
       infus.over 1 hr. Max.dly dos: 1 g.  imp.ren.funct., Li tox.report.with diuret.& ACE inhibit.  MYLAN INDAPAMIDE, Mylan
       Contraindications: Sulphon.hypersens., incr. azotaem. & oligur.dur.  LASIX, Sanofi-Aventis   Indapamide.
       treatm.of sev.progress.ren. dis., hepat.coma, electrol.deplet., hypovol-  Furosemide.  Indications: Mild to mod.hypertens.indiv./in combinat.
       aem., hypotens., anur./ren.fail.due to nephrotox.or hepatotox.drugs,   Indications: Oed., ascites & ac.pulmon.oed., mild to mod.hypertens.,   (S3) TABS. 29/7.1/0590
       precomat.states assoc.with hepat.cirrhos., lactat., Addison’s dis.,   barbit.poison.(forced diuresis), burns.  703329-001: 2,5 mg, 30, R18,63
       pre-exist. hypercalcaem., safety in pregn.not est.  (S3) TABS. E/18.1/201, 202, V/18.1/9.  Dosage: 1 tab.dly.in the morn. Further reduct.may be combin.with
       Side effects: Fluid & electrol.imbal., revers. deafn. & tinnit.with   735930-007: 20 mg, 30, R146,11  other antihypertens.
       rapid IV infus., perman.deafn. with imp.ren.funct., skin reacts.incl.  735949-018: 40 mg, 30, R174,88  Contra-indications: Sev.hepat./ren.insuffic., hypokalaem., safety
       photosens.& erythema multiforme, N&V, diarrh., blurr./yell.vis., diz-  735949-026: 40 mg, 250, R1 457,46  in pregn.& childr.not est., Addison’s, exist.hypercalcaem., concom.Li.
       zin., headache, pancreatit., musc.spasm, cramps, hypotens., allerg.  780839-005: 80 mg, 30, R563,81  Side-effects: Hyperglycaem.& glycosur.in diab. & other suscept.
       reacts., cholestat.jaund., bone marr.depress., bld.dyscras., hyperuri-  (S3) INJ. H1777. 10 mg/ml.  pts., hyperuricaem., may precipit. gout, electrol.imbal., hypercal-
       caem. with gout precipitat., low.ser.Ca lev., dehydrat.& reduc. bld.  735981-019: 5x2 ml, R83,10  caem., hypomagnesaem., seiz., GI disturbs., headache, dizzin.,
       vol.with circulat.collaps.& poss.vasc. thrombos. partic.in elderly,   (S3) SOL. N/18.1/6. 10 mg/ml.  photosens.reacts., postur.hypotens., paraesthes., impot., yell.vis.,
       nephrocalcinos.in preterm.infts.  839515-006: 100 ml, R349,75  hypersens.reacts., cholest.jaund., pancreatit., bld.dyscras., poss.
       Special precautions: Monit.fluid & electrol.bal., prostat.hypertrohy,   Dosage: IV/IM admin.is indicat.in all cases where intest. absorpt.  unmask diab.mellit.
       imp.micturit., may precipit. diab. mellit.,digital.tox.poss.precipitat.with   imp./if prompt diures.reqd. Admin. IV inj.slow.not exceed.rate of 4   Special precautions: Concom.diurets. poss. caus.hypokalaem.not
       excess. K loss & concom.card.glycos., K deplet.steroids, concom.ceph-  mg/min. Durat.of treatm. at physic.descret.  recomm., elderly pts. partic. suscept. to electrol.imbal., imp.ren./hepat.
           -
                       -
       alospor.& ototox.meds., imp.ren./ hepat.funct., diab.mellit., adren.dis.  Adults: 20-80 mg as sngl.dose in morn, if necess. 6 hrs. aft.40 mg   funct., cirrhos. pts., poss.diab.agents dos.adjustm., poss. hyponatraem.
       Drug interactions: Neuromusc.block.act.of non-depolar.musc.relax.  dose admin.80 mg & if necess. admin. 120 mg aft.another 6 hrs.   in sev.CHF where pts.are very oedemat. with high dos.in conjunct. with
       enhanc., alcoh./barbit.& narcot.enhanc.post.hypotens., tox.Li bld.conc.  Maint: 20-40 mg dly. Admin.dly.dos.exceed.120 mg in 2-3 div.dos.  restrict. diet.salt, SLE may be exacerb/activ.in suscept.pts.
       FUROBE, (Ranbaxy) Be-Tabs     Hypertens: 40-80 mg dly.     Drug interactions: May enhanc.toxic.of digital. glycosides, enhanc.
       Furosemide.                   Pulm.oed: Init.40 mg IV, rep.aft.20 mins.if necess.  neuromusc.block.act.of competit.musc.relax., eff.of antihypertens.
       Indications: Oed.of card./hepat./ren.origin, refract.oed., symptomat.  Forced diures: 20-40 mg in addit.to infus.of electrol.sol.  agents poss.enhanc., postur.hypotens.poss.enhanc.by comcom.al-
                                                                  coh., barbitur./opoids, the K  deplet.eff. enhanc.by corticoster., corti-
                                                                              +
       hypercalcaem., mild to mod.hypertens.  Infts.& childr.und.15 yrs: Oral dos: 2 mg/kg bm/ day in div. doses.
       (S3) TABS. S/18.1/31          Titr.to max.of 6 mg/kg. Parenter dos: 1 mg/kg/bm/day given only   cotrophin/ carbenoxolone, tox.Li bld.conc.
       821845-012: 40 mg, 250, R52,77  in life-threaten. condits. Max.20 mg/day.  NATRILIX SR, Servier
       Dosage: Adults: 40 mg dly.,may be incr.to 200 mg dly.if necess.   (S3) RETARD CAPS. J/18.1/5.  Indapamide.
       Admin.dly.doses exceed.120 mg in 2-3 div.doses. Maint.therapy   Indications: Prolong.diures., oed.due to venous insuffic.& aft.thrombos.  Indications: Mild to mod.hypertens.
       20-40 mg dly.                 735973-008: 60 mg 30, R325,64  (S3) SR TABS, 31/7.1/0166.
       Childr: 1 mg/kg bm/day, may be incr.to 3 mg/kg bm/ day if necess.  Dosage: Adults: Oed: 60 mg dly./on altern.days in mild cases.  830836-004: 1,5 mg, 30, R129,28
       not exceed.120 mg/dly         Hypertens: 60 mg dly. May be incr.to 120 mg dly or more in sev.  Dosage: One SR tab.in the morn. In more sev. cases may be combin.
       Contraindications: Azotaem.& oligur., hepat. coma, electrol.  cases. Maint.dos.depend.indiv. response.  with other antihypertens.
       deplet., lactat.              (S3) TABS, D/18.1/266        Contraindications: Sev.hepat.insuff., hypersens. to other sul-
       Side effects: Hyperuricaem., metab.alkalos., K deplet., dermatit.,   735957-010: 500 mg, 100, R5 553,23  phonamide type meds., sev.ren.fail. (creatinine clear.&lt;36 ml/min),
       postur.hypotens., N&V, blurr. vis., bld.dyscras., imp.gluc.tol., dehydr.&   Indications: Ac./chron.ren.fail.with filtrat.below 20 ml/min., chron.  safety in pregn.not est.
       reduct.of bld. vol.with poss.circulat.collapse, electrol. disturbs., vasc.  ren.insuffic.in predialyt.stage, ac. ren.fail.in post-op phase & in assoc.  Side effects: Giddin., headache, GI disturbs., postur. hypotens.,
       thrombos.& embol.esp.in elderly, excess. K-loss in pts.receiv.card.gly-  with septic process., nephrot.syndr.  electrol.imbal., hypersens. reacts.
       cosid.precipit. digital. toxic.  Dosage: Gen. 1-4 tabs aft.breakf., if adeq. diures. not achiev.within   Special precautions: Ren.insuff., K  supplem. may be reqd., monit.
                                                                                  +
       Special precautions: K-deplet.steroid therapy.  4-6 hrs incr.init.dose by ½-1 tab.  uric acid lev., monit.ser.K in pts.prone/sens.to hypokalaem.as no sig-
                                                                             +
       Drug interactions: Poss.nephrotoxic.with concom. cephalospor.  Chron.ren.insuff: Init. 250 mg, if no adeq. respons. in 4-6 hrs.incr.by   nif.diures. is usual.produc.
       aminoglycosid.poss.enhanc. ototoxic.  ½ tab 4-6 hrly.until effect.dose achiev.(gen.betw. ½-4 tabs.).  Drug interactions: Could potent.other diuret</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page247.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page243.html">243</a>&nbsp;&nbsp;&nbsp;<a href="page244.html">244</a>&nbsp;&nbsp;&nbsp;<a href="page245.html">245</a>&nbsp;&nbsp;&nbsp;<a href="page246.html">246</a>&nbsp;&nbsp;&nbsp;<a href="page247.html">247</a>&nbsp;&nbsp;&nbsp;<a href="page248.html">248</a>&nbsp;&nbsp;&nbsp;<a href="page249.html">249</a>&nbsp;&nbsp;&nbsp;<a href="page250.html">250</a>&nbsp;&nbsp;&nbsp;<a href="page251.html">251</a>&nbsp;&nbsp;&nbsp;<a href="page252.html">252</a>&nbsp;&nbsp;&nbsp;<a href="page253.html">253</a>
             </td>
             <td width="35%"><a href="page249.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page249.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
